List view / Grid view
Bruker today introduces the new CTX™ X-ray fluorescence (XRF) elemental analyzer. The portable Counter Top XRF (CTX) is small, light-weight, safety-interlocked, and battery operated. At less than 7 kilograms in weight, the self-contained CTX is truly portable, and has a small footprint of 14 cm in width...
First of a new class of anti-cancer agents to reach clinical trials...
Scientists report that by combining a robotic arm and mass spectrometry can potentially open up new branches of pharmaceutics...
Better timing for cortisol replacement therapies, to more closely replicate the secretion patterns of people with normal levels of the hormone, has shown a significant improvement in patients' cognitive function...
Scientists have created a non-invasive, adhesive patch, which promises the measurement of glucose levels through the skin without a finger-prick blood test...
Children with intellectual difficulty or autism are more likely to be given antipsychotic medication from a younger age than those without intellectual disability...
Scientists have developed a new drug treating skin lesions in tuberous sclerosis complex (TSC), a rare intractable disease...
Scientists show how the gonorrhoea bacterium resists last-resort antibiotic ceftriaxone while maintaining a robust growth rate...
Sirolimus, which is used to prevent rejection after kidney transplants has been used to treat idiopathic pulmonary neuroendocrine cell hyperplasia...
A drug that has helped millions of people around the world manage their diabetes may also help people ready to kick their nicotine habits...
New research points to the important role that benzodiazepines may have in depression...
Poor animal study design and reporting prevent the ethical review of proposed human drug trials, according to a team of international researchers...
A new blood test has been found to more accurately predict the development of tuberculosis up to two years before its onset in people living with someone with active TB...
Visit Booth 2833 to see how Watson-Marlow Fluid Technology Group is able to work with you at every process step...
New study suggests that using a two-drug combination of currently available treatment could be more effective for most lung cancers.
